Analysis of predicted CD8+ T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis

被引:16
|
作者
Wang, Jiuling [1 ]
Zhang, Hongmei [2 ]
Wang, Honghai [1 ]
机构
[1] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Shanghai 200433, Peoples R China
[2] Henan Inst Med Sci, Zhengzhou, Henan, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Epitope; HLA class I binding; Mycobacterium tuberculosis; Region of difference; BOVIS BCG; HLA-B; ANTIGEN; IMMUNITY; MICE; IDENTIFICATION; RESPONSES; EFFICACY; ALLELES;
D O I
10.1007/s11033-009-9613-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of regions designated as RD1-RD16 (region of difference) and encompassing 129 open reading frames have been identified between Mycobacterium tuberculosis and Mycobacterium bovis on the one hand and Bacillus Calmette-Gu,rin on the other. Identification of T cell epitopes from this set of proteins may serve to define candidate antigens with potentials in specific diagnosis and development of new vaccines against TB. All possible nonameric peptide sequences from proteins of these M. tuberculosis specific regions were analyzed in silico for the ability to bind to 33 alleles of class I HLA. These results reveal that of all RD proteins, a significant number of these peptides are predicted to be high-affinity HLA binders (T (1/2) a parts per thousand yen 100 min), irrespective of the length of the protein, and 67% of the peptides predicted to bind are mono-allelic in their binding. Pathogen peptides that could behave as self- or partially self-peptides in the host were eliminated using a comparative study with the human proteome, thus the number of peptides for analysis was reduced. The predicted epitopes can be tested experimentally for their inclusion in a potential vaccine against tuberculosis and specific diagnosis.
引用
收藏
页码:1793 / 1799
页数:7
相关论文
共 50 条
  • [41] Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner
    Moliva, J. I.
    Hossfeld, A. P.
    Canan, C. H.
    Dwivedi, V.
    Wewers, M. D.
    Beamer, G.
    Turner, J.
    Torrelles, J. B.
    MUCOSAL IMMUNOLOGY, 2018, 11 (03) : 968 - 978
  • [42] IL-15 protects antigen-specific CD8+ T cell contraction after Mycobacterium bovis bacillus Calmette-Guerin infection
    Tang, Ce
    Yamada, Hisakata
    Shibata, Kensuke
    Yoshida, Shin-ichi
    Wajjwalku, Worawidh
    Yoshikai, Yasunobu
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (01) : 187 - 194
  • [43] A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis
    Martins, V. T.
    Duarte, M. C.
    Lage, D. P.
    Costa, L. E.
    Carvalho, A. M. R. S.
    Mendes, T. A. O.
    Roatt, B. M.
    Menezes-Souza, D.
    Soto, M.
    Coelho, E. A. F.
    PARASITE IMMUNOLOGY, 2017, 39 (01)
  • [44] Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells
    Karimzadeh, Hadi
    Kiraithe, Muthamia M.
    Kosinska, Anna D.
    Glaser, Manuel
    Fiedler, Melanie
    Oberhardt, Valerie
    Alizei, Elahe Salimi
    Hofmann, Maike
    Mok, Juk Yee
    Nguyen, Melanie
    van Esch, Wim J. E.
    Budeus, Bettina
    Grabowski, Jan
    Homs, Maria
    Olivero, Antonella
    Keyvani, Hossein
    Rodriguez-Frias, Francisco
    Tabernero, David
    Buti, Maria
    Heinold, Andreas
    Alavian, Seyed Moayed
    Bauer, Tanja
    Wiesch, Julian Schulze Zur
    Raziorrouh, Bijan
    Hoffmann, Daniel
    Smedile, Antonina
    Rizzetto, Mario
    Wedemeyer, Heiner
    Timm, Joerg
    Antes, Iris
    Neumann-Haefelin, Christoph
    Protzer, Ulrike
    Roggendorf, Michael
    JOURNAL OF VIROLOGY, 2018, 92 (13)
  • [45] Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells
    van der Wulp, Willemijn
    Remst, Dennis F. G.
    Kester, Michel G. D.
    Hagedoorn, Renate S.
    Parren, Paul W. H. I.
    van Kasteren, Sander I.
    Schuurman, Janine
    Hoeben, Rob C.
    Ressing, Maaike E.
    Bleijlevens, Boris
    Heemskerk, Mirjam H. M.
    CANCER GENE THERAPY, 2024, 31 (01) : 58 - 68
  • [46] Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen
    Wei Luo
    Xiao-Bing Zhang
    Yong-Ta Huang
    Pei-Pei Hao
    Zhen-Min Jiang
    Qian Wen
    Ming-Qian Zhou
    Qi Jin
    Li Ma
    Journal of Molecular Medicine, 2011, 89 : 903 - 913
  • [47] STING Ligand-Mediated Priming of Functional CD8+ T Cells Specific for HIV-1-Protective Epitopes from Naive T Cells
    Kuse, Nozomi
    Akahoshi, Tomohiro
    Takiguchi, Masafumi
    JOURNAL OF VIROLOGY, 2021, 95 (16)
  • [48] Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen
    Luo, Wei
    Zhang, Xiao-Bing
    Huang, Yong-Ta
    Hao, Pei-Pei
    Jiang, Zhen-Min
    Wen, Qian
    Zhou, Ming-Qian
    Jin, Qi
    Ma, Li
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2011, 89 (09): : 903 - 913
  • [49] SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross- reactive CMV- specific T cells
    Pothast, Cilia R.
    Dijkland, Romy C.
    Thaler, Melissa
    Hagedoorn, Renate S.
    Kester, Michel G. D.
    Wouters, Anne K.
    Hiemstra, Pieter S.
    van Hemert, Martijn J.
    Gras, Stephanie
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    ELIFE, 2022, 11
  • [50] Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children
    Bodewes, Rogier
    Fraaij, Pieter L. A.
    Geelhoed-Mieras, Martina M.
    van Baalen, Carel A.
    Tiddens, Harm A. W. M.
    van Rossum, Annemarie M. C.
    van der Klis, Fiona R.
    Fouchier, Ron A. M.
    Osterhaus, Albert D. M. E.
    Rimmelzwaan, Guus F.
    JOURNAL OF VIROLOGY, 2011, 85 (22) : 11995 - 12000